Financial Disclosure by Clinical Investigators: Guidance for Clinical Investigators, Industry,and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 1, 2013
August 10, 2023
a2fdcaf8-673b-4e11-9017-f37e4d719af8
Related Documents
Considerations When Transferring Clinical Investigation Oversight to Another IRB: Guidance for IRBs, Clinical Investigators, and Sponsors
Guidance DocumentMay 23, 2014Office of the Commissioner
Electronic Source Data in Clinical Investigations: Guidance for Industry
Guidance DocumentSeptember 18, 2013Center for Drug Evaluation and Research
Adverse Event Reporting to IRBs — Improving Human Subject Protection: Guidance for Clinical Investigators, Sponsors, and IRBs
Guidance DocumentJanuary 14, 2009Office of the Commissioner
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox